ELMSFORD, N.Y.--(BUSINESS WIRE)--BioScrip (NASDAQ: BIOS) today announced that on Monday, January 31, 2011 at 5:00 PM Eastern Standard Time, Richard M. Smith, President and Chief Executive Officer, and David W. Froesel, Executive Vice President, Chief Financial Officer and Treasurer, will provide an update on the Company’s ongoing strategic assessment to improve financial and operational performance. A live audio webcast of the event may be accessed at http://event.on24.com/r.htm?e=281225&s=1&k=F40F8B406EEC34EBA87AE83ACFB7E16C.
Interested parties may participate in the conference call by dialing (866) 464-2449 (US), or (973) 935-2840 (International), 5-10 minutes prior to the start of the call. Please reference conference call ID number: 39798876. A replay of the conference call will be available for 48 hours after the call's completion by dialing (800) 642-1687 and entering conference call ID number: 39798876. An audio webcast and archive will also be available for 90 days under the “Investor Relations” section of the BioScrip website at http://www.bioscrip.com.
About BioScrip
BioScrip, Inc. (www.bioscrip.com) (Nasdaq: BIOS) is a national provider of specialty pharmacy and home care products and services that partners with patients, physicians, hospitals, healthcare payors and pharmaceutical manufacturers to provide clinical management solutions and delivery of cost-effective access to prescription medications. Our services are designed to improve clinical outcomes for chronic and acute healthcare conditions while controlling overall healthcare costs.
Forward Looking Statements-Safe Harbor
Statements contained in this press release that express a belief, expectation, anticipation or intent are considered forward-looking statements and are protected under the Safe Harbor of Private Securities Litigation and Reform Act. These forward-looking statements are based on information available to the Company today, and the Company assumes no obligation to update statements as circumstances change. These forward-looking statements may involve a number of risks and uncertainties, which may cause the Company's results to differ materially from such statements.
Forward-looking statements are subject to inherent risks and uncertainties surrounding future expectations generally and may differ materially from actual future experience. Risks and uncertainties that could affect forward-looking statements include the failure to realize annualized cost savings associated with any restructuring or cost reduction efforts, our ability to leverage core competencies or maximize margins and operating cash flow generation, and the risks described from time to time in the Company’s reports filed with the SEC, including the Company’s annual report on Form 10-K for the year ended December 31, 2009 and the Company’s quarterly reports on Form 10-Q for the quarters ended March 31, 2010, June 30, 2010 and September 30, 2010.